Navigation Links
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
Date:5/11/2012

/#!documentDetail;D=FDA-2011-D-0618-0025">http://www.regulations.gov/#!documentDetail;D=FDA-2011-D-0618-0025.  The deadline for submitting written comments following the hearing is May 25, 2012.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com. Follow us on www.twitter.com/amgen.

Forward-Looking Statements

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2011, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. 

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company's results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sa
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen to Present at the Baird Growth Stock Conference
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
4. Amgen Announces Webcast of 2012 First Quarter Financial Results
5. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
6. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
7. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
8. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
9. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
10. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
11. Amgen Announces Final Results of Its Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Fla. and DUBLIN , Jan. ... the agreement with KRS Global Biotechnology, Inc. for the compounding, ... be compounded for shipment in the United States ... FDA approved Outsourcing Facility capable of compounding naltrexone tablets in ...
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
(Date:1/22/2015)... (PRWEB) January 23, 2015 Angelweddingdress is a ... business invites its customers to follow it on Facebook, Twitter, ... a Valentine’s Day gift. Angelweddingdress draws a lottery every week. ... Sale to Feb. 28, 2015. Click Angelweddingdress homepage ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Payday lending ... vulnerable communities and cause financial distress to the states ... analysts at Howard University’s Center on Race and Wealth. ... in economic activity, payday loans at the same time ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... to Patients and Physicians -, ADDISON, Texas, ... ),today announced that it has launched a new ... care professionals and patients on,the clinical benefits of ... of the use of,Altrazeal(TM) and product attributes and ...
... Will Be Featured at ASN, EL SEGUNDO, ... of kidney care services for those diagnosed with ... Research(R) (DCR),recently contributed fifteen abstracts to the 41st ... of Nephrology. These,abstracts were developed both internally and ...
... XOMA Ltd. (Nasdaq:,XOMA), a leader in the discovery ... host a conference call and webcast on,Monday, November 10 ... 2008,financial results and provide a general business update., ... third quarter 2008,financial results earlier that morning. The webcast ...
... The Quantum Group,Inc. (Amex: QGP ), ... Noel J. Guillama, President & Chief Executive Officer,will ... on November 12, 2008. Mr. Guillama will be ... Technology & Innovations Officer,and Ron Smith, Senior Vice ...
... Nov. 4 /PRNewswire-FirstCall/ - Haemacure Corporation,(TSX:HAE) announced today ... Haemacure, will present at the Rodman and Renshaw ... New York. Mr. Galli will,present a corporate progress ... candidate, Hemaseel(R)HMN (fibrin sealant). The Haemacure,presentation is scheduled ...
... CorVel Corporation,(Nasdaq: CRVL ) reported earnings per share of ... in the same quarter of the prior,year. For the six ... to the same period in the prior year of $0.79 ... million, up from prior,year quarterly revenues of $74 million. For ...
Cached Medicine News:Health News:ULURU Inc. Announces the Launch of the Altrazeal(TM) Website 2Health News:ULURU Inc. Announces the Launch of the Altrazeal(TM) Website 3Health News:DaVita Abstracts Accepted into American Society of Nephrology Meeting 2Health News:DaVita Abstracts Accepted into American Society of Nephrology Meeting 3Health News:DaVita Abstracts Accepted into American Society of Nephrology Meeting 4Health News:XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10 2Health News:XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10 3Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 2Health News:The Quantum Group Inc. To Present at Paulson Investment's 31st Annual Westergaard Conference 3Health News:Haemacure to Present at the Rodman & Renshaw Annual Global Investor Conference 2Health News:CorVel Announces Second Quarter Revenues and Earnings 2Health News:CorVel Announces Second Quarter Revenues and Earnings 3Health News:CorVel Announces Second Quarter Revenues and Earnings 4
Straight shafts with 1 x 2 teeth. Serrated handle, non-magnetic and polished finish....
Straight shafts with 1 x 2 teeth. Flat handle with haoles and polished finish. Delicate teeth. Most popular size or model....
Atraumatic forceps with fine 1 mm ring tips provide firm grasp without the damage caused by tooth or serrated forceps. Wide serrated handle. Polished finish....
Titanium. 0.12 mm 1 x 2 teeth with 7 mm platform. Flat serrated handle with dull finish....
Medicine Products: